In addition, preclinical evidence on GLP-1 effects in directly modulating the hypothalamus–pituitary–gonadal (HPG) axis, or the effects of GLP-1RA on clinical and biochemical expression of hyperandrogenism, concern new aspects in PCOS which are probably not always related to weight loss. The gene discussed is GLP1R; the disease is hyperandrogenism.